Prozac (Fluoxetine) Capsules

Prozac is the well-known brand name for oral fluoxetine capsules, a selective serotonin reuptake inhibitor (SSRI) that has shaped modern depression treatment since its US approval in the late 1980s. We offer Prozac capsules in 10 mg, 20 mg, 40 mg, and 60 mg strengths, packed in quantities suited to shorter supplies and longer-term maintenance therapy. This article explains what fluoxetine does in the body, how prescribers typically use it, what to expect during treatment, and how Prozac relates to generic fluoxetine and other therapeutic alternatives.

What Prozac Is and How It Fits Into Antidepressant Treatment

Fluoxetine, the active ingredient in every Prozac capsule, belongs to the SSRI class (ATC code N06AB03), a group of medicines that changed psychiatric practice by offering effective treatment with a generally more tolerable adverse-effect profile than older tricyclic antidepressants and monoamine oxidase inhibitors. Each capsule contains fluoxetine hydrochloride equivalent to the stated dose of fluoxetine. We supply the conventional immediate-release oral capsule rather than a delayed-release or liquid formulation, so the strengths and package options described on this page apply specifically to these capsules.

Inactive capsule ingredients can matter to people with a known dye, gelatin, or excipient allergy. Patients with such allergies should check the ingredient information supplied with their particular package and ask a pharmacist before use. Capsules are swallowed by mouth and are not intended to be opened, crushed, or used by another route unless a prescriber or pharmacist gives product-specific instructions.

Depression, OCD, and Related Conditions Fluoxetine Is Used to Treat

Major depressive disorder is a persistent low mood accompanied by changes in sleep, appetite, energy, concentration, and interest in daily activities that lasts most of the day, nearly every day, for at least two weeks. Obsessive-compulsive disorder (OCD) produces intrusive, unwanted thoughts paired with repetitive behaviors performed to reduce the distress those thoughts cause. Bulimia nervosa involves cycles of binge eating followed by compensatory behaviors, while panic disorder causes recurrent, sudden episodes of intense fear with physical symptoms such as a racing heart or shortness of breath.

Prozac capsules have established uses in major depressive disorder, OCD, bulimia nervosa, and panic disorder. Fluoxetine is also used for premenstrual dysphoric disorder (PMDD), which causes severe mood and physical symptoms tied to the menstrual cycle, although that US indication has historically been associated with fluoxetine marketed under the Sarafem name rather than the Prozac label. A prescriber should determine whether a particular fluoxetine product and regimen are appropriate for the diagnosed condition.

How Fluoxetine Works in the Brain

Serotonin is a neurotransmitter involved in mood regulation, appetite, sleep, and impulse control. Under normal conditions, neurons release serotonin into the synaptic gap and then reabsorb it through a transporter protein, ending its signaling effect. Fluoxetine selectively blocks that serotonin transporter, leaving more serotonin available in the synapse for longer and strengthening serotonergic signaling across relevant neural circuits. Unlike older antidepressants, fluoxetine has little direct effect on norepinephrine or dopamine reuptake, which contributes to its different adverse-effect profile.

The biological action starts before a patient feels a clinical change. Fluoxetine reaches the bloodstream within hours, but receptor regulation, neural adaptation, and changes in gene expression develop gradually. Some patients notice changes in sleep, appetite, anxiety, or energy within the first few weeks, while a fuller antidepressant response commonly takes four to eight weeks. OCD symptoms may require an even longer adequate trial. Early activation does not necessarily predict the eventual benefit, but severe agitation or worsening mood requires prompt clinical review.

What the Evidence Shows

Fluoxetine was one of the most extensively studied antidepressants of the 1980s and 1990s, with randomized, placebo-controlled trials establishing efficacy in major depressive disorder and later trials extending the evidence base to OCD, bulimia nervosa, and panic disorder. Meta-analyses spanning decades of research, including pediatric depression and OCD data, show a statistically meaningful average advantage over placebo. They also show that response varies: some patients improve substantially, some obtain partial benefit, and others need a dose adjustment, psychotherapy, or a different medicine.

Evidence for an antidepressant describes outcomes across groups rather than guaranteeing an individual result. Diagnosis, symptom severity, adherence, coexisting illness, other medicines, and the duration of an adequate trial all affect response. Fluoxetine's large evidence base and long clinical history are among the reasons it remains a common first-line or early-line option, but tolerability and previous treatment response still guide product choice.

Strengths, Package Options, and General Dosing Principles

We currently list Prozac capsules in 10 mg, 20 mg, 40 mg, and 60 mg strengths. Package sizes vary by strength: 10 mg and 40 mg capsules are available in counts of 100, 200, 300, and 400, while 20 mg and 60 mg capsules come in counts of 30, 60, 90, and 120. These options allow customers to select the strength and capsule count specified for their treatment plan.

Adult dosing depends on the diagnosis. Major depressive disorder and OCD treatment commonly begins with 20 mg in the morning, although a lower starting dose may be chosen for a patient who is sensitive to activating effects, has substantial comorbidity, or is taking interacting medicines. Panic disorder commonly starts at 10 mg daily before increasing to 20 mg daily. The established adult regimen for bulimia nervosa is 60 mg daily. These examples describe general labeled approaches, not a personal dosing instruction; prescribers may adjust the regimen according to response, tolerability, age, liver function, and the condition being treated.

Fluoxetine is commonly taken once daily in the morning. If a prescriber divides a higher total daily dose, doses are generally taken in the morning and at noon rather than late in the day, because fluoxetine can cause insomnia or activation. Capsules may be taken with or without food; taking a dose with food may help if nausea occurs. A consistent daily time supports adherence. Patients should not double a dose after a missed capsule or change, stop, or restart treatment without individualized guidance.

Children and adolescents require age- and indication-specific prescribing. Fluoxetine has established pediatric use for major depressive disorder from age 8 and OCD from age 7, but dose selection, growth, weight, behavioral changes, and antidepressant-related suicidality require close monitoring. Older adults and people with significant liver impairment may need a lower dose or less frequent administration because elimination can be slower.

Elimination and Half-Life

Fluoxetine has one of the longest half-lives among commonly used antidepressants, averaging roughly one to three days after a single dose and extending to about four to six days during regular dosing. Its active metabolite, norfluoxetine, has a half-life of approximately four to 16 days. Fluoxetine is extensively metabolized in the liver through pathways that include CYP2D6, and metabolites are eliminated largely in urine.

This extended elimination profile means fluoxetine and norfluoxetine can remain in the body for several weeks after the last capsule. It helps explain why one missed dose may produce fewer immediate discontinuation symptoms than a missed dose of a shorter-acting SSRI. It also means interactions can persist after treatment stops, and it does not make an intentional discontinuation plan unnecessary. Switching to an MAOI or another strongly interacting medicine requires particular attention to the long washout period.

Important Safety Information

Fluoxetine carries a boxed warning about an increased risk of suicidal thoughts and behaviors in children, adolescents, and young adults taking antidepressants, especially during the first months of treatment and after a dose change. Families and caregivers should watch for abrupt changes in mood, behavior, sleep, agitation, impulsivity, or suicidal thinking. New or worsening suicidal thoughts require urgent contact with a clinician; an immediate danger warrants calling 911 or going to an emergency department.

Antidepressants can precipitate mania or hypomania in someone with bipolar disorder, so screening for a personal or family history of bipolar illness is important before treatment. Other uncommon but serious risks include serotonin syndrome, seizures, low blood sodium, abnormal bleeding, angle-closure glaucoma in susceptible patients, and heart-rhythm effects in patients with relevant risk factors or interacting medicines. Fluoxetine can alter blood glucose control, causing hypoglycemia during treatment or hyperglycemia after discontinuation, so patients with diabetes may need closer glucose monitoring and adjustment of insulin or oral diabetes medicine.

Because fluoxetine may impair judgment, thinking, or coordination, patients should avoid driving or operating hazardous machinery until they know how it affects them. Pregnancy requires an individualized assessment of the risks of untreated maternal illness and potential fetal or neonatal effects, including complications after late-pregnancy exposure. Fluoxetine and norfluoxetine enter human milk, and breastfed infants should be observed for agitation, irritability, poor feeding, or inadequate weight gain when treatment is considered necessary.

Monitoring generally includes symptom response, suicidal thinking, activation, sleep, adherence, and adverse effects. Weight and growth deserve attention in younger patients, while sodium monitoring may be appropriate for older adults, people taking diuretics, or anyone who develops headache, confusion, weakness, or unsteadiness. Patients with diabetes should follow the glucose-monitoring plan set by their clinician.

Prescription Status and Ordering Prozac Through Us

Fluoxetine is authorized for human medicinal use in the United States, and oral fluoxetine capsules are prescription medications. That regulatory classification is separate from the documentation our own ordering process may request to accept an order. Customers who need to confirm our current order-acceptance requirements should contact our support team before checkout.

We offer the 10 mg, 20 mg, 40 mg, and 60 mg strengths in the package quantities listed above. Ireland RX has supported customers since 2008, and our pharmacist-supported team is available 24/7 by email, online chat, and phone for questions about an order or general product information. Questions requiring personal diagnosis, prescribing, or a change in treatment should be directed to the patient's prescriber.

Who Should Avoid Fluoxetine

Fluoxetine is contraindicated in patients with known hypersensitivity to fluoxetine or any capsule ingredient. An unrelated or unspecified allergy history is not, by itself, a fluoxetine-specific contraindication, but a previous serious reaction to this medicine requires avoidance.

Fluoxetine must not be used concurrently with a monoamine oxidase inhibitor (MAOI) or within the required washout period because the combination can cause life-threatening serotonin syndrome. At least 14 days should generally pass after stopping an MAOI before fluoxetine begins, and at least five weeks should pass after stopping fluoxetine before an MAOI begins; a longer interval may be needed in some circumstances. Starting fluoxetine in a patient receiving linezolid or intravenous methylene blue is also generally avoided because these agents can inhibit monoamine oxidase.

Concurrent use with pimozide or thioridazine is contraindicated because fluoxetine's CYP2D6 inhibition and the medicines' cardiac effects can increase the risk of dangerous rhythm abnormalities. Thioridazine should not be started until at least five weeks after fluoxetine has been stopped.

Interactions to Discuss With a Prescriber or Pharmacist

Fluoxetine is a clinically important CYP2D6 inhibitor and can raise concentrations of medicines that depend on that enzyme for clearance. Examples include some tricyclic antidepressants, antipsychotics, antiarrhythmics, and other medicines with a narrow therapeutic range. It can also reduce conversion of tamoxifen to its active metabolite, so patients taking tamoxifen should have the combination reviewed by the clinicians managing their treatment.

Combining fluoxetine with serotonergic medicines or supplements increases the risk of serotonin syndrome. Relevant examples include other antidepressants, triptans, tramadol, lithium, buspirone, amphetamines, fentanyl, tryptophan, and St. John's wort. Symptoms can include agitation, confusion, sweating, diarrhea, fever, rapid heart rate, muscle rigidity, tremor, or overactive reflexes and require urgent assessment.

SSRIs can increase bleeding risk, particularly when combined with aspirin, nonsteroidal anti-inflammatory drugs such as ibuprofen or naproxen, antiplatelet medicines, or anticoagulants such as warfarin. Alcohol may worsen dizziness, impaired judgment, or drowsiness and is best discussed with the prescriber. A pharmacist should review prescription medicines, nonprescription products, vitamins, and herbal supplements before fluoxetine starts and whenever another treatment is added or stopped.

Side Effects and When to Seek Help

Common adverse effects include nausea, diarrhea, headache, insomnia, anxiety, nervousness, sweating, tremor, fatigue, dry mouth, reduced appetite, and sexual dysfunction. Some patients experience weight change or vivid dreams. Gastrointestinal effects and early jitteriness often improve as the body adjusts, but persistent or disruptive symptoms should be discussed rather than managed by changing the dose without guidance.

Prompt medical attention is appropriate for a marked worsening of mood, new suicidal thoughts, severe agitation, symptoms of mania, unusual bleeding, fainting, a seizure, or signs of low sodium such as confusion, severe weakness, or unsteadiness. Facial swelling, widespread hives, blistering rash, or difficulty breathing may indicate a serious allergic reaction and requires emergency care. High fever, marked agitation, muscle rigidity, tremor, and rapid heart rate may indicate serotonin syndrome and should not wait for a routine follow-up.

Fluoxetine should not be stopped solely because an early adverse effect appears unless emergency care is needed. A prescriber can assess whether the symptom is temporary, whether timing or dose should change, or whether another medicine would be safer. Although its long half-life reduces abrupt concentration changes, discontinuation symptoms and return of the underlying condition can still occur.

Overdose and Emergency Situations

Fluoxetine has a wider safety margin in overdose than older tricyclic antidepressants, but an overdose can still be serious, particularly when other medicines are involved. Reported effects include nausea, vomiting, agitation, seizures, altered consciousness, abnormal heart rhythms, blood-pressure changes, and serotonin syndrome. Severe outcomes are more likely with mixed overdoses, and apparent wellness shortly after ingestion does not rule out later complications.

There is no specific antidote for fluoxetine overdose; hospital management focuses on airway and cardiovascular support, symptom treatment, and appropriate monitoring. If an overdose is suspected, call 911 or Poison Help at 1-800-222-1222 immediately, or go to the nearest emergency department. Bring the capsule packaging if it can be done safely so responders can identify the strength and likely amount involved. Do not induce vomiting unless a poison-control professional specifically instructs you to do so.

Storing Your Prozac Capsules

Store Prozac capsules at controlled room temperature between 59°F and 86°F, in a tightly closed container away from moisture and direct light. A consistent, dry location is preferable to a bathroom cabinet exposed to steam. Keep the medicine out of the sight and reach of children and pets, and do not use capsules beyond the labeled expiration date.

A medicine take-back program is the preferred way to dispose of unwanted or expired capsules. If a take-back option is not readily available, follow the disposal instructions supplied with the medicine or current FDA and local guidance for household disposal. Do not flush fluoxetine unless specific disposal instructions direct you to do so.

Weighing the Benefits and Limitations

Fluoxetine's long track record, broad range of established uses, once-daily administration, and long half-life are practical advantages. Its persistence in the body can make an occasional missed dose less disruptive and may reduce abrupt discontinuation symptoms compared with shorter-acting SSRIs. Fluoxetine can also be relatively activating, which may help some patients troubled by low energy but may aggravate insomnia, restlessness, or anxiety in others.

Trade-offs include the delayed onset shared by antidepressant treatment, a meaningful interaction burden from CYP2D6 inhibition, sexual adverse effects, and the long wait required before certain interacting medicines can safely begin. A long half-life is therefore both an advantage and a limitation: adverse effects and interactions may take longer to resolve. Treatment choice should reflect diagnosis, prior response, coexisting illness, other medicines, and the patient's priorities rather than familiarity with a brand name alone.

Prozac, Generic Fluoxetine, and Other Antidepressants

Generic fluoxetine contains the same active ingredient as brand-name Prozac and, when supplied as an approved equivalent in the same strength and dosage form, is expected to provide comparable clinical exposure. The choice is often influenced by availability, cost, capsule ingredients, and personal preference rather than a different core mechanism. Patients should still check the label when a manufacturer changes because capsule appearance and inactive ingredients can differ.

Other SSRIs include sertraline, escitalopram, citalopram, paroxetine, and fluvoxamine. They share serotonin reuptake inhibition but differ meaningfully in half-life, activation or sedation, withdrawal burden, cardiac considerations, approved uses, and enzyme interactions. Sertraline has a shorter half-life and relatively modest CYP2D6 inhibition but may produce more gastrointestinal effects. Escitalopram generally has fewer enzyme interactions, while paroxetine has a short half-life, stronger discontinuation effects, and anticholinergic characteristics. Fluvoxamine is commonly associated with OCD treatment and has its own substantial interaction profile.

Serotonin-norepinephrine reuptake inhibitors such as venlafaxine add norepinephrine effects at therapeutic doses and may have different blood-pressure, withdrawal, and tolerability considerations. Older tricyclic antidepressants and MAOIs remain useful in selected cases but generally require more intensive attention to toxicity and interactions. None of these medicines should be substituted, overlapped, or switched without prescriber guidance because washout and tapering requirements depend on the pharmacology of both treatments.